The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development
Abstract
The drug discovery process of ruthenium and osmium anticancer therapeutics is described, including global structure–activity relationships.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,689
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985
Self-citationMechanisms of action of arsenic trioxide.
Miller, W. H., Schipper, H. M., Lee, J. S., Singer, J. W., & Waxman, S. (2002) · PubMed · Cited by 956
Rademaker-Lakhai, J. M., van den Bongard, D., Pluim, D., Beijnen, J. H., & Schellens, J. H. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0746 · Cited by 833
Hartinger, C. G., Jakupec, M. A., Zorbas‐Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Dyson, P. J., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890195 · Cited by 830
Self-citationSecond Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
Travis, L. B., Fosså, S. D., Schonfeld, S. J., McMaster, M. L., Lynch, C. F., Storm, H., Hall, P., Holowaty, E., Andersen, A., Pukkala, E., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji278 · Cited by 823
Inhibition of Cancer Cell Growth by Ruthenium(II) Arene Complexes
Morris, R. E., Aird, R. E., del Socorro Murdoch, P., Chen, H., Cummings, J., Hughes, N. D., Parsons, S., Parkin, A., Boyd, G., Jodrell, D. I., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010051m · Cited by 787
In Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes
Scolaro, C., Bergamo, A., Brescacín, L., Delfino, R., Cocchietto, M., Laurenczy, G., Geldbach, T. J., Sava, G., & Dyson, P. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050015d · Cited by 784
Ruthenium metallopharmaceuticals
Clarke, M. J. (2003) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00312-0 · Cited by 687
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Trondl, R., Heffeter, P., Kowol, C. R., Jakupec, M. A., Berger, W., & Keppler, B. K. (2014) · Chem. Sci. · doi:10.1039/c3sc53243g · Cited by 675
Self-citationAreneruthenium complexes as anticancer agents
Süß‐Fink, G. (2009) · Dalton Transactions · doi:10.1039/b916860p · Cited by 652
Timerbaev, A. R., Hartinger, C. G., Aleksenko, S. S., & Keppler, B. K. (2006) · Chemical Reviews · doi:10.1021/cr040704h · Cited by 614
Self-citationAird, R. E., Cummings, J., Ritchie, A. A., Muir, M., Morris, R. E., Chen, H., Sadler, P. J., & Jodrell, D. I. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600290 · Cited by 582
Metal-based anticancer chemotherapeutic agents
Muhammad, N., & Guo, Z. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.02.003 · Cited by 515
Approaching tumour therapy beyond platinum drugs
Bergamo, A., Gaiddon, C., Schellens, J. H. M., Beijnen, J. H., & Sava, G. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.09.030 · Cited by 514
Auranofin: Repurposing an Old Drug for a Golden New Age
Roder, C., & Thomson, M. J. (2015) · Drugs in R&D · doi:10.1007/s40268-015-0083-y · Cited by 497
Allardyce, C. S., Dyson, P. J., Ellis, D. J., & Heath, S. L. (2001) · Chemical Communications · doi:10.1039/b104021a · Cited by 495
Bridging solubility between drug discovery and development
Di, L., Fish, P. V., & Mano, T. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.11.007 · Cited by 491
Habtemariam, A., Melchart, M., Fernández, R., Parsons, S., Oswald, I. D. H., Parkin, A., Fabbiani, F. P. A., Davidson, J. E., Dawson, A., Aird, R. E., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060596m · Cited by 456
The role of the medicinal chemist in drug discovery — then and now
Lombardino, J. G., & Lowe, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1523 · Cited by 452
Cisplatin (cis-diamminedichloroplatinum II)
Prestayko, A. W., D'Aoust, J. C., Issell, B. F., & Crooke, S. T. (1979) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(79)80057-2 · Cited by 405
Next-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Romero-Canelón, I., & Sadler, P. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400835n · Cited by 396
Leijen, S., Burgers, S. A., Baas, P., Pluim, D., Tibben, M., van Werkhoven, E., Alessio, E., Sava, G., Beijnen, J. H., & Schellens, J. H. M. (2015) · Investigational New Drugs · doi:10.1007/s10637-014-0179-1 · Cited by 374
Designing organometallic compounds for catalysis and therapy
Noffke, A. L., Habtemariam, A., Pizarro, A. M., & Sadler, P. J. (2012) · Chemical Communications · doi:10.1039/c2cc30678f · Cited by 370
Carboplatin versus cisplatin in solid tumors: An analysis of the literature
Lokich, J., & Anderson, N. (1998) · Annals of Oncology · doi:10.1023/a:1008215213739 · Cited by 304
Catalytic organometallic anticancer complexes
Dougan, S. J., Habtemariam, A., McHale, S. E., Parsons, S., & Sadler, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800076105 · Cited by 303
Global Proteome Analysis of the NCI-60 Cell Line Panel
Gholami, A. M., Hahne, H., Wu, Z., Auer, F. J., Meng, C., Wilhelm, M., & Kuster, B. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.018 · Cited by 302
Adhireksan, Z., Davey, G. E., Campomanes, P., Groessl, M., Clavel, C. M., Yu, H., Nazarov, A. A., Yeo, C. H. F., Ang, W. H., Dröge, P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4462 · Cited by 297
Organometallic Cages as Vehicles for Intracellular Release of Photosensitizers
Schmitt, F., Freudenreich, J., Barry, N. P. E., Juillerat-Jeanneret, L., Süss-Fink, G., & Therrien, B. (2012) · Journal of the American Chemical Society · doi:10.1021/ja207784t · Cited by 293
Shi, G., Monro, S., Hennigar, R., Colpitts, J., Fong, J., Kasimova, K., Yin, H., DeCoste, R., Spencer, C., Chamberlain, L., et al. (2015) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.04.012 · Cited by 279
Targeted and multifunctional arene ruthenium chemotherapeutics
Smith, G. S., & Therrien, B. (2011) · Dalton Transactions · doi:10.1039/c1dt11007a · Cited by 262
Chatterjee, S., Kundu, S., Bhattacharyya, A., Hartinger, C. G., & Dyson, P. J. (2008) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-008-0400-9 · Cited by 258
Self-citationWang, F., Chen, H., Parsons, S., Oswald, I. D. H., Davidson, J. E., & Sadler, P. J. (2003) · Chemistry – A European Journal · doi:10.1002/chem.200304724 · Cited by 254
Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
Nowak-Sliwinska, P., van Beijnum, J. R., Casini, A., Nazarov, A. A., Wagnières, G., van den Bergh, H., Dyson, P. J., & Griffioen, A. W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2002074 · Cited by 248
Bertrand, B., Stefan, L., Pirrotta, M., Monchaud, D., Bodio, E., Richard, P., Le Gendre, P., Warmerdam, E., de Jager, M. H., Groothuis, G. M. M., et al. (2014) · Inorganic Chemistry · doi:10.1021/ic403011h · Cited by 245
Lentz, F., Drescher, A., Lindauer, A., Henke, M., Hilger, R. A., Hartinger, C. G., Scheulen, M. E., Dittrich, C., Keppler, B. K., & Jaehde, U. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328322fbc5 · Cited by 239
Self-citationInteractions between mammalian cell DNA and inorganic platinum compounds—I
Pascoe, J. M., & Roberts, J. J. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90354-2 · Cited by 236
Ruthenium Half‐Sandwich Complexes Bound to Protein Kinase Pim‐1
Debreczeni, J. É., Bullock, A. N., Atilla, G. E., Williams, D. S., Bregman, H., Knapp, S., & Meggers, E. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503468 · Cited by 234
Meng, X., Leyva, M. L., Jenny, M., Gross, I., Benosman, S., Fricker, B., Harlepp, S., Hébraud, P., Boos, A., Wlosik, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4408 · Cited by 208
Dorcier, A., Ang, W. H., Bolaño, S., Gonsalvi, L., Juillerat-Jeannerat, L., Laurenczy, G., Peruzzini, M., Phillips, A. D., Zanobini, F., & Dyson, P. J. (2006) · Organometallics · doi:10.1021/om060394o · Cited by 203
Modulation of the metastatic progression of breast cancer with an organometallic ruthenium compound
Bergamo (1992) · International Journal of Oncology · doi:10.3892/ijo_00000119 · Cited by 202
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells
Kapitza, S., Pongratz, M., Jakupec, M. A., Heffeter, P., Berger, W., Lackinger, L., Keppler, B. K., & Marian, B. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0617-0 · Cited by 200
Self-citationActivation Mechanisms for Organometallic Anticancer Complexes
Pizarro, A. M., Habtemariam, A., & Sadler, P. J. (2010) · Topics in Organometallic Chemistry · doi:10.1007/978-3-642-13185-1_2 · Cited by 199
Özaslan, M., Karagöz, I. D., Kılıç, İ. H., & Güldür, M. E. (2011) · AFRICAN JOURNAL OF BIOTECHNOLOGY · Cited by 189
Mendoza-Ferri, M. G., Hartinger, C. G., Mendoza, M. A., Groessl, M., Egger, A. E., Eichinger, R. E., Mangrum, J. B., Farrell, N. P., Maruszak, M., Bednarski, P. J., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8013234 · Cited by 185
Self-citationA Ruthenium Antimetastasis Agent Forms Specific Histone Protein Adducts in the Nucleosome Core
Wu, B., Ong, M. S., Groessl, M., Adhireksan, Z., Hartinger, C. G., Dyson, P. J., & Davey, C. A. (2011) · Chemistry – A European Journal · doi:10.1002/chem.201100298 · Cited by 174
Self-citationDevelopment of anticancer agents: wizardry with osmium
Hanif, M., Babak, M. V., & Hartinger, C. G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.016 · Cited by 172
Self-citationWang, F., Xu, J., Habtemariam, A., Bella, J., & Sadler, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053387k · Cited by 169
Dougan, S. J., Melchart, M., Habtemariam, A., Parsons, S., & Sadler, P. J. (2006) · Inorganic Chemistry · doi:10.1021/ic061460h · Cited by 162
Hartinger, C. G., Groessl, M., Meier, S. M., Casini, A., & Dyson, P. J. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35532b · Cited by 157
Self-citationBurris, H. A., Bakewell, S. J., Bendell, J. C., Infante, J. R., Jones, S. F., Spigel, D. R., Weiss, G. J., Ramanathan, R. K., Ogden, A., & Hoff, D. D. V. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000154 · Cited by 157
Approaches to the design of catalytic metallodrugs
Soldevila‐Barreda, J. J., & Sadler, P. J. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.01.024 · Cited by 152
Kurzwernhart, A., Kandioller, W., Bächler, S., Bartel, C., Martić, S., Buczkowska, M., Mühlgassner, G., Jakupec, M. A., Kraatz, H., Bednarski, P. J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301376a · Cited by 147
Self-citationAnticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60
Hu, D., Liu, Y., Lai, Y., Tong, K., Fung, Y. M. E., Lok, C., & Che, C. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201509612 · Cited by 144
New Ruthenium Complexes for the Treatment of Cancer
Keppler, B. K., Henn, M., Juhl, U. M., Berger, M. R., Niebl, R., & Wagner, F. E. (1989) · Progress in clinical biochemistry and medicine · doi:10.1007/978-3-642-74760-1_3 · Cited by 143
Self-citationvan Rijt, S., Mukherjee, A., Pizarro, A. M., & Sadler, P. J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901556u · Cited by 142
Babak, M. V., Meier, S. M., Huber, K., Reynisson, J., Legin, A. A., Jakupec, M. A., Roller, A., Stukalov, A., Gridling, M., Bennett, K. L., et al. (2015) · Chemical Science · doi:10.1039/c4sc03905j · Cited by 141
Self-citationStewart, J. J., White, J. T., Yan, X. S., Collins, S. J., Drescher, C. W., Urban, N. D., Hood, L., & Lin, B. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500140-mcp200 · Cited by 140
Kurzwernhart, A., Kandioller, W., Bartel, C., Bächler, S., Trondl, R., Mühlgassner, G., Jakupec, M. A., Arion, V. B., Marko, D., Keppler, B. K., et al. (2012) · Chemical Communications · doi:10.1039/c2cc31040f · Cited by 138
Self-citationMeier, S. M., Hanif, M., Adhireksan, Z., Pichler, V., Novak, M. S., Jirkovsky, E., Jakupec, M. A., Arion, V. B., Davey, C. A., Keppler, B. K., et al. (2013) · Chemical Science · doi:10.1039/c3sc22294b · Cited by 134
Self-citationOrganometallic Osmium Arene Complexes with Potent Cancer Cell Cytotoxicity
Fu, Y., Habtemariam, A., Pizarro, A. M., van Rijt, S., Healey, D. J., Cooper, P. A., Shnyder, S. D., Clarkson, G. J., & Sadler, P. J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100560f · Cited by 132
Bijelic, A., Theiner, S., Keppler, B. K., & Rompel, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00600 · Cited by 128
Self-citationAn Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin
Meier, S. M., Kreutz, D., Winter, L., Klose, M. H. M., Cseh, K., Weiss, T., Bileck, A., Alte, B., Mader, J. C., Jana, S., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201702242 · Cited by 125
Self-citationReactions of a Ruthenium(II) Arene Antitumor Complex with Cysteine and Methionine
Wang, F., Chen, H., Parkinson, J. A., Murdoch, P. D. S., & Sadler, P. J. (2002) · Inorganic Chemistry · doi:10.1021/ic025538f · Cited by 121
Bytzek, A. K., Koellensperger, G., Keppler, B. K., & Hartinger, C. G. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.02.037 · Cited by 114
Self-citationLitkouhi, B., Kwong, J., Lo, C., et al. (2007) · Neoplasia · doi:10.1593/neo.07118 · Cited by 113
Berndsen, R. H., Weiss, A., Abdul, U. K., Wong, T. J., Meraldi, P., Griffioen, A. W., Dyson, P. J., & Nowak-Sliwinska, P. M. (2017) · Scientific Reports · doi:10.1038/srep43005 · Cited by 113
Organometallic Osmium(II) Arene Anticancer Complexes Containing Picolinate Derivatives
van Rijt, S., Peacock, A. F. A., Johnstone, R. D. L., Parsons, S., & Sadler, P. J. (2009) · Inorganic Chemistry · doi:10.1021/ic8020222 · Cited by 112
van Rijt, S., Hebden, A. J., Amaresekera, T., Deeth, R. J., Clarkson, G. J., Parsons, S., McGowan, P. C., & Sadler, P. J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900731j · Cited by 107
Stebler-Roethlisberger, M., Hummel, W., Pittet, P. A., et al. (1988) · Inorganic Chemistry · doi:10.1021/ic00281a009 · Cited by 107
Hanif, M., Henke, H., Meier, S. M., Martić, S., Labib, M., Kandioller, W., Jakupec, M. A., Arion, V. B., Kraatz, H., Keppler, B. K., et al. (2010) · Inorganic Chemistry · doi:10.1021/ic1009785 · Cited by 104
Self-citationGifford, J. B., Huang, W., Zeleniak, A. E., Hindoyan, A. A., Wu, H., Donahue, T. R., & Hill, R. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0774 · Cited by 104
Ginzinger, W., Mühlgassner, G., Arion, V. B., Jakupec, M. A., Roller, A., Galanski, M. S., Reithofer, M. R., Berger, W., & Keppler, B. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3000906 · Cited by 104
Self-citationFu, Y., Romero, M. J., Habtemariam, A., Snowden, M. E., Song, L., Clarkson, G. J., Qamar, B., Pizarro, A. M., Unwin, P. R., & Sadler, P. J. (2012) · Chemical Science · doi:10.1039/c2sc20220d · Cited by 101
Metal-Based Paullones as Putative CDK Inhibitors for Antitumor Chemotherapy
Schmid, W. F., John, R. O., Mühlgassner, G., Heffeter, P., Jakupec, M. A., Galanski, M. S., Berger, W., Arion, V. B., & Keppler, B. K. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701042w · Cited by 89
Self-citationSerum-protein interactions with anticancer Ru(III) complexes KP1019 and KP418 characterized by EPR
Cetinbas, N. M., Webb, M. I., Dubland, J. A., & Walsby, C. J. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0578-5 · Cited by 85
Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells
Hearn, J. M., Romero‐Canelón, I., Munro, A. F., Fu, Y., Pizarro, A. M., Garnett, M. J., McDermott, U., Carragher, N. O., & Sadler, P. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500925112 · Cited by 84
Hu, L., Cheng, T., He, B., Li, L., Wang, Y., Lai, Y., Jiang, G., & Sun, H. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201300794 · Cited by 83
Fu, Y., Habtemariam, A., Basri, A. M., Braddick, D., Clarkson, G. J., & Sadler, P. J. (2011) · Dalton Transactions · doi:10.1039/c1dt10937e · Cited by 79
Anti-colorectal cancer activity of an organometallic osmium arene azopyridine complex
Shnyder, S. D., Fu, Y., Habtemariam, A., van Rijt, S., Cooper, P. A., Loadman, P. M., & Sadler, P. J. (2011) · MedChemComm · doi:10.1039/c1md00075f · Cited by 69
Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity
Betanzos-Lara, S., Nováková, O., Deeth, R. J., Pizarro, A. M., Clarkson, G. J., Lišková, B., Brabec, V., Sadler, P. J., & Habtemariam, A. (2012) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-012-0917-9 · Cited by 68
Riedl, C. A., Flocke, L. S., Hejl, M., Roller, A., Klose, M. H. M., Jakupec, M. A., Kandioller, W., & Keppler, B. K. (2016) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.6b02430 · Cited by 66
Self-citationBytzek, A. K., Boeck, K., Hermann, G., et al. (2011) · Metallomics · doi:10.1039/c1mt00055a · Cited by 64
Filak, L. K., Göschl, S., Heffeter, P., Samper, K. G., Egger, A., Jakupec, M. A., Keppler, B. K., Berger, W., & Arion, V. B. (2013) · Organometallics · doi:10.1021/om3012272 · Cited by 63
Self-citationMeier, S. M., Novak, M. S., Kandioller, W., Jakupec, M. A., Arion, V. B., Metzler‐Nolte, N., Keppler, B. K., & Hartinger, C. G. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201300889 · Cited by 62
Self-citationWolters, D. A., Stefanopoulou, M., Dyson, P. J., & Groessl, M. (2012) · Metallomics · doi:10.1039/c2mt20070h · Cited by 62
Filak, L. K., Mühlgassner, G., Bacher, F., Roller, A., Galanski, M. S., Jakupec, M. A., Keppler, B. K., & Arion, V. B. (2010) · Organometallics · doi:10.1021/om101004z · Cited by 58
Self-citationFilak, L. K., Mühlgassner, G., Jakupec, M. A., Heffeter, P., Berger, W., Arion, V. B., & Keppler, B. K. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-010-0653-y · Cited by 58
Self-citationDepenbrock, H., Schmelcher, S., Peter, R., Keppler, B. K., Weirich, G., Block, T. R., Rastetter, J., & Hanauske, A.-R. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00277-3 · Cited by 54
Self-citationLizardo, M. M., Morrow, J. J., Miller, T. E., Hong, E. S., Ren, L., Mendoza, A., Halsey, C. H., Scacheri, P. C., Helman, L. J., & Khanna, C. (2016) · Neoplasia · doi:10.1016/j.neo.2016.09.001 · Cited by 50
Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs
Schreiber‐Brynzak, E., Klapproth, E., Unger, C., Lichtscheidl, I., Göschl, S., Schweighofer, S., Trondl, R., Dolznig, H., Jakupec, M. A., & Keppler, B. K. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0260-4 · Cited by 48
Self-citationArtner, C., Holtkamp, H. U., Hartinger, C. G., & Meier, S. M. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.07.010 · Cited by 45
Self-citationHackl, C. M., Legina, M. S., Pichler, V., Schmidlehner, M., Roller, A., Dömötör, O., Enyedy, É. A., Jakupec, M. A., Kandioller, W., & Keppler, B. K. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201603206 · Cited by 41
Self-citationJatoi, A., Breitkopf, C. R., Foster, N. R., Block, M. S., Grudem, M. E., Hendrickson, A. W., Carlson, R. E., Barrette, B. A., Karlin, N. J., & Fields, A. P. (2014) · Oncology · doi:10.1159/000369257 · Cited by 36
Hanif, M., Schaaf, P., Kandioller, W., Hejl, M., Jakupec, M. A., Roller, A., Keppler, B. K., & Hartinger, C. G. (2010) · Australian Journal of Chemistry · doi:10.1071/ch10232 · Cited by 35
Self-citationBlazevic, A., Hummer, A. A., Heffeter, P., Berger, W., Filipits, M., Cibin, G., Keppler, B. K., & Rompel, A. (2017) · Scientific Reports · doi:10.1038/srep40966 · Cited by 32
Self-citationIn vivo evaluation of small-molecule thermoresponsive anticancer drugs potentiated by hyperthermia
Clavel, C. M., Nowak-Sliwinska, P. M., Păunescu, E., Griffioen, A. W., & Dyson, P. J. (2015) · Chemical Science · doi:10.1039/c5sc00613a · Cited by 31
Artner, C., Holtkamp, H. U., Kandioller, W., Hartinger, C. G., Meier, S. M., & Keppler, B. K. (2017) · Chemical Communications · doi:10.1039/c7cc04582d · Cited by 31
Self-citationKwong, W., Lam, K., Lok, C., Lai, Y., Lee, P., & Che, C. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201608094 · Cited by 27
Zur experimentellen Therapie der Tumoren
Collier, W. A., & Krauß, F. (1931) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01625394 · Cited by 17
Fuereder, T., & Berger, W. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000239 · Cited by 16
Self-citationBergamo, A., Gerdol, M., Lucafò, M., Pelillo, C., Battaglia, M., Pallavicini, A., & Sava, G. (2015) · Metallomics · doi:10.1039/c5mt00081e · Cited by 12
Lectin–Gd-Loaded Chitosan Hydrogel Nanoparticles: A New Biospecific Contrast Agent for MRI
Pashkunova-Martic, I., Kremser, C., Galanski, M. S., Arion, V. B., Debbage, P. L., Jaschke, W. R., & Keppler, B. K. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0309-x · Cited by 12
Self-citation
Research works printed but not linked: 82
- Lay, 1991, Adv. Inorg. Chem., 37, 219, 10.1016/S0898-8838(08)60008-2 · doi:10.1016/s0898-8838(08)60008-2
- Ono, 2012, Oncol. Lett., 4, 905, 10.3892/ol.2012.842 · doi:10.3892/ol.2012.842
- Coskun, 2008, Neoplasma, 55, 65
- Durig, 1976, Chem.-Biol. Interact., 13, 287, 10.1016/0009-2797(76)90081-8 · doi:10.1016/0009-2797(76)90081-8
- Clarke, 1974, J. Am. Chem. Soc., 96, 5413, 10.1021/ja00824a016 · doi:10.1021/ja00824a016
- Clarke, 1978, J. Am. Chem. Soc., 100, 5068, 10.1021/ja00484a026 · doi:10.1021/ja00484a026
- Kelman, 1977, J. Clin. Hematol. Oncol., 7, 274
- Clarke, 1980, J. Inorg. Biochem., 12, 79, 10.1016/S0162-0134(00)80045-8 · doi:10.1016/s0162-0134(00)80045-8
- Clarke, 1980, Inorg. Chem., 19, 1103, 10.1021/ic50206a078 · doi:10.1021/ic50206a078
- Keppler, 1986, J. Cancer Res. Clin. Oncol., 111, 166, 10.1007/BF00400758 · doi:10.1007/bf00400758
- Keppler, 1987, Inorg. Chem., 26, 4366, 10.1021/ic00273a018 · doi:10.1021/ic00273a018
- Berger, 1989, Anticancer Res., 9, 761
- Dhubhghaill, 1994, J. Chem. Soc., Dalton Trans., 3305, 10.1039/DT9940003305 · doi:10.1039/dt9940003305
- Chatlas, 1995, Inorg. Chim. Acta, 233, 59, 10.1016/0020-1693(94)04447-4 · doi:10.1016/0020-1693(94)04447-4
- Smith, 1996, J. Biol. Inorg. Chem., 1, 424, 10.1007/s007750050074 · doi:10.1007/s007750050074
- Trynda-Lemiesz, 1999, J. Inorg. Biochem., 73, 123, 10.1016/S0162-0134(99)00004-5 · doi:10.1016/s0162-0134(99)00004-5
- Pieper, 1998, Analusis, 26, M84, 10.1051/analusis:1998155 · doi:10.1051/analusis:1998155
- Thompson, 2012, J. Clin. Oncol., 30, 3033, 10.1200/jco.2012.30.15_suppl.3033 · doi:10.1200/jco.2012.30.15_suppl.3033
- Monti-Bragadin, 1975, Antimicrob. Agents Chemother., 7, 825, 10.1128/AAC.7.6.825 · doi:10.1128/aac.7.6.825
- Alessio, 1988, Inorg. Chem., 27, 4099, 10.1021/ic00296a006 · doi:10.1021/ic00296a006
- Sava, 1989, Pharmacol. Res., 21, 617, 10.1016/1043-6618(89)90204-1 · doi:10.1016/1043-6618(89)90204-1
- Alessio, 1991, Inorg. Chem., 30, 609, 10.1021/ic00004a005 · doi:10.1021/ic00004a005
- Sava, 1992, Anti-Cancer Drugs, 3, 25, 10.1097/00001813-199202000-00005 · doi:10.1097/00001813-199202000-00005
- Sava, 1994, Drug Invest., 8, 150, 10.1007/BF03259431 · doi:10.1007/bf03259431
- Casini, 2010, ChemMedChem, 5, 1989, 10.1002/cmdc.201000331 · doi:10.1002/cmdc.201000331
- Mestroni, 1994, Metal-Based Drugs, 1, 41, 10.1155/MBD.1994.41 · doi:10.1155/mbd.1994.41
- Sava, 1998, Pathol. Oncol. Res., 4, 30, 10.1007/BF02904692 · doi:10.1007/bf02904692
- Gopal, 1999, Biochemistry, 38, 4382, 10.1021/bi981990s · doi:10.1021/bi981990s
- Velders, 2000, Inorg. Chem., 39, 2966, 10.1021/ic000167t · doi:10.1021/ic000167t
- Hotze, 2000, Inorg. Chem., 39, 3838, 10.1021/ic000066v · doi:10.1021/ic000066v
- Yan, 2005, Chem. Commun., 4764, 10.1039/b508531b · doi:10.1039/b508531b
- Allardyce, 2001, Platinum Met. Rev., 45, 62, 10.1595/003214001X4526269 · doi:10.1595/003214001x4526269
- Ang, 2006, Inorg. Chem., 45, 9006, 10.1021/ic061008y · doi:10.1021/ic061008y
- Ozaslan, 2011, Afr. J. Biotechnol., 10, 2375
- Bergamo, 2008, Int. J. Oncol., 33, 1281
- Wu, 2008, Nat. Chem. Biol., 4, 110, 10.1038/nchembio.2007.58 · doi:10.1038/nchembio.2007.58
- Aird, 2001, Br. J. Cancer, 85, 101
- Cummings, 2000, Clin. Cancer Res., 6, 4494s
- Guichard, 2006, Biochem. Pharmacol., 71, 408, 10.1016/j.bcp.2005.10.053 · doi:10.1016/j.bcp.2005.10.053
- Bergamo, 2010, J. Inorg. Biochem., 104, 79, 10.1016/j.jinorgbio.2009.10.005 · doi:10.1016/j.jinorgbio.2009.10.005
- Chen, 2002, J. Am. Chem. Soc., 124, 3064, 10.1021/ja017482e · doi:10.1021/ja017482e
- Chen, 2003, J. Am. Chem. Soc., 125, 173, 10.1021/ja027719m · doi:10.1021/ja027719m
- Wang, 2005, J. Biol. Inorg. Chem., 10, 147, 10.1007/s00775-004-0621-5 · doi:10.1007/s00775-004-0621-5
- Dorcier, 2005, Organometallics, 24, 2114, 10.1021/om049022a · doi:10.1021/om049022a
- Peacock, 2006, J. Am. Chem. Soc., 128, 1739, 10.1021/ja055886r · doi:10.1021/ja055886r
- Peacock, 2007, Inorg. Chem., 46, 4049, 10.1021/ic062350d · doi:10.1021/ic062350d
- Cebrian-Losantos, 2007, Inorg. Chem., 46, 5023, 10.1021/ic700405y · doi:10.1021/ic700405y
- Buchel, 2011, Inorg. Chem., 50, 7690, 10.1021/ic200728b · doi:10.1021/ic200728b
- Groessl, 2007, J. Med. Chem., 50, 2185, 10.1021/jm061081y · doi:10.1021/jm061081y
- Kostrhunova, 2008, J. Med. Chem., 51, 3635, 10.1021/jm701538w · doi:10.1021/jm701538w
- Hung, 1981, Inorg. Chem., 20, 457, 10.1021/ic50216a028 · doi:10.1021/ic50216a028
- S. H. van Rijt , A. F. A.Peacock and P. J.Sadler , in Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy – Molecular Mechanisms and Clinical Applications , ed. A. Bonetti , R. Leone , F. M. Muggia and S. B. Howell , Humana Press , New York , 2009 , pp. 73–79 10.1007/978-1-60327-459-3_10 · doi:10.1007/978-1-60327-459-3_10
- Hartinger, 2012, Organometallics, 31, 5677, 10.1021/om300373t · doi:10.1021/om300373t
- McKeage, 2000, Cancer Chemother. Pharmacol., 46, 343, 10.1007/s002800000166 · doi:10.1007/s002800000166
- Mendoza-Ferri, 2009, Organometallics, 28, 6260, 10.1021/om900715j · doi:10.1021/om900715j
- Serli, 2005, Eur. J. Inorg. Chem., 3423, 10.1002/ejic.200500210 · doi:10.1002/ejic.200500210
- Akbayeva, 2003, Chem. Commun., 264, 10.1039/b210102e · doi:10.1039/b210102e
- Weber, 1986, Inorg. Chem., 25, 1088, 10.1021/ic00228a007 · doi:10.1021/ic00228a007
- Magennis, 2007, Inorg. Chem., 46, 5059, 10.1021/ic062111q · doi:10.1021/ic062111q
- Hanif, 2010, Dalton Trans., 39, 7345, 10.1039/c003085f · doi:10.1039/c003085f
- Peacock, 2007, Chem. – Eur. J., 13, 2601, 10.1002/chem.200601152 · doi:10.1002/chem.200601152
- Peacock, 2007, J. Am. Chem. Soc., 129, 3348, 10.1021/ja068335p · doi:10.1021/ja068335p
- Schmid, 2007, Organometallics, 26, 6643, 10.1021/om700813c · doi:10.1021/om700813c
- Berger, 2008, Chem. – Eur. J., 14, 9046, 10.1002/chem.200801032 · doi:10.1002/chem.200801032
- Hanif, 2011, J. Inorg. Biochem., 105, 224, 10.1016/j.jinorgbio.2010.10.004 · doi:10.1016/j.jinorgbio.2010.10.004
- Kasser, 2010, J. Organomet. Chem., 695, 875, 10.1016/j.jorganchem.2010.01.007 · doi:10.1016/j.jorganchem.2010.01.007
- Kandioller, 2009, Organometallics, 28, 4249, 10.1021/om900483t · doi:10.1021/om900483t
- Kandioller, 2009, J. Organomet. Chem., 694, 922, 10.1016/j.jorganchem.2008.10.016 · doi:10.1016/j.jorganchem.2008.10.016
- Kandioller, 2009, Chem. – Eur. J., 15, 12283, 10.1002/chem.200901939 · doi:10.1002/chem.200901939
- Schmidlehner, 2016, Dalton Trans., 45, 724, 10.1039/C5DT02722E · doi:10.1039/c5dt02722e
- S. M. Meier , PhD thesis, University of Vienn a , 2013
- Klose, 2017, Analyst, 142, 2327, 10.1039/C7AN00350A · doi:10.1039/c7an00350a
- Mendes, 2017, Anti-Cancer Agents Med. Chem., 17, 126, 10.2174/1871520616666160922165133 · doi:10.2174/1871520616666160922165133
- Pernot, 2012, J. Photochem. Photobiol., B, 117, 80, 10.1016/j.jphotobiol.2012.08.012 · doi:10.1016/j.jphotobiol.2012.08.012
- Dickson, 2011, J. Clin. Oncol., 29, 2607, 10.1200/jco.2011.29.15_suppl.2607 · doi:10.1200/jco.2011.29.15_suppl.2607
- Zorzet, 2001, Metal-Based Drugs, 8, 1, 10.1155/MBD.2001.1 · doi:10.1155/mbd.2001.1
- Groessl, 2008, Electrophoresis, 29, 2224, 10.1002/elps.200780790 · doi:10.1002/elps.200780790
- Cocchietto, 2000, Pharmacol. Toxicol., 87, 193, 10.1034/j.1600-0773.2000.d01-73.x · doi:10.1034/j.1600-0773.2000.d01-73.x
- Yoshida, 2011, Anticancer Res., 31, 1271
- Guidi, 2013, J. Inorg. Biochem., 118, 94, 10.1016/j.jinorgbio.2012.10.003 · doi:10.1016/j.jinorgbio.2012.10.003
- Kreutz, 2017, Chem. – Eur. J., 23, 1881, 10.1002/chem.201604516 · doi:10.1002/chem.201604516
- Miller, Jr., 2002, Cancer Res., 62, 3893
Cited by
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium
Konkankit, C. C., Marker, S. C., Knopf, K. M., & Wilson, J. J. (2018) · Dalton Transactions · doi:10.1039/c8dt01858h · Cited by 284
Metallodrugs in cancer nanomedicine
Peña, Q., Wang, A., Zaremba, O., Shi, Y., Scheeren, H. W., Metselaar, J. M., Kiessling, F., Pallares, R. M., Wuttke, S., & Lammers, T. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00468a · Cited by 259
Metadata
- Authors
- Meier-Menches, S. M., Gerner, C., Berger, W., Hartinger, C. G., & Keppler, B. K.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2018
- Volume
- 47
- Issue
- 3
- Pages
- 909-928
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2770473333
- Cited by
- 425
- References
- 107
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.